Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 27:15:819.
doi: 10.18632/oncotarget.28678.

Retraction: miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1

Affiliations

Retraction: miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1

Chuntao Li et al. Oncotarget. .
No abstract available

PubMed Disclaimer

Retraction of

References

    1. Shi Y, Huang J, Zhou J, Liu Y, Fu X, Li Y, Yin G, Wen J. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1. Oncol Rep. 2015; 34:399–406. 10.3892/or.2015.3986. . Retraction in: Oncol Rep. 2021; 46:147. DOI: https://doi.org/10.3892/or.2021.8098 PMID: 34080647 - DOI - PubMed
    1. Lai C, Chen Z, Li R. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1. Mol Med Rep. 2015; 12:1473–8. 10.3892/mmr.2015.3545. . Retraction in: Mol Med Rep. 2021; 24:546. DOI: https://doi.org/10.3892/mmr.2021.12185 PMID: 34080019 - DOI - PubMed
    1. Jiao A, Sui M, Zhang L, Sun P, Geng D, Zhang W, Wang X, Li J. MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator. Mol Med Rep. 2016; 13:3349–55. 10.3892/mmr.2016.4901. . Retraction in: Mol Med Rep. 2021; 24:573. DOI: https://doi.org/10.3892/mmr.2021.12212 PMID: 34109435 - DOI - PubMed
    1. Zhang C, Long F, Wan J, Hu Y, He H. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2. Oncol Rep. 2016; 35:3275–84. 10.3892/or.2016.4700. . Retraction in: Oncol Rep. 2021; 46:155. DOI: 10.1002/jcla.24893 PMID: 34109990 - DOI - PubMed

Publication types

LinkOut - more resources